Davis's Drug Guide
maribavir
General
Pronunciation:
ma-rye-ba-vir
Trade Name(s)
- Livtencity
Ther. Class.
Pharm. Class.
kinase inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Maribavir." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580062/1/maribavir.
Vallerand AHA, Sanoski CAC. Maribavir. Davis's Drug Guide. F.A. Davis Company; 2026. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580062/1/maribavir. Accessed June 29, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Maribavir. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580062/1/maribavir
Vallerand AHA, Sanoski CAC. Maribavir [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 29]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580062/1/maribavir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - maribavir
ID - 3580062
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580062/1/maribavir
PB - F.A. Davis Company
ET - 20
DB - Nursing Central
DP - Unbound Medicine
ER -
